SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS
申请人:Biocryst Pharmaceuticals, Inc.
公开号:EP3687506A1
公开(公告)日:2020-08-05
[EN] ENDOTHELIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR DE L'ENDOTHELINE
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:WO1995033752A1
公开(公告)日:1995-12-14
(EN) A compound of formulas (Ia), (Ib) and (Ic) and use as endothelin receptor antagonists.(FR) L'invention concerne un composé de formules (Ia, Ib et Ic) et son utilisation en tant qu'antagoniste du récepteur de l'endothéline.
[EN] SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS<br/>[FR] BENZOFURANE, BENZOPYRROLE, BENZOTHIOPHÈNE SUBSTITUÉS ET INHIBITEURS DU COMPLÉMENT STRUCTURELLEMENT APPARENTÉS
申请人:BIOCRYST PHARM INC
公开号:WO2019195720A1
公开(公告)日:2019-10-10
Disclosed are compounds of formulae I and II, and pharmaceutically acceptable salts and prodrugs thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity.